Time to Oncological Surgery: Impact of Treatment Delays on Tumor Progression, Clinical Outcomes, and Healthcare Efficiency
DOI:
https://doi.org/10.64784/308Palabras clave:
oncological surgery, treatment delay, time to surgery, tumor progression, cancer survival, surgical waiting time, healthcare efficiency, oncological outcomes, resectability, cancer careResumen
Delays between cancer diagnosis and definitive oncological surgery have become an increasingly relevant concern due to their potential impact on tumor progression, clinical outcomes, and healthcare efficiency. This study analyzed available evidence regarding the relationship between surgical waiting times and oncological outcomes in adult patients with solid tumors, with particular emphasis on breast, colorectal, lung, pancreatic, bladder, and head and neck cancers. A structured integrative review was conducted using the Scientific Method, incorporating systematic reviews, meta-analyses, population-based studies, and observational cohorts. The analysis focused on time from diagnosis to surgery, overall and disease-specific survival, pathological upstaging, recurrence, resectability, postoperative outcomes, treatment complexity, and healthcare-related factors. The findings showed that prolonged and avoidable delays were generally associated with less favorable outcomes, although the magnitude of the effect varied according to tumor type, stage, biological aggressiveness, and treatment sequence. Across several surgical indications, each additional four-week delay was associated with an approximate 6–8% increase in mortality hazard, while specific studies also demonstrated greater pathological upstaging, reduced long-term survival, and loss of surgical opportunity with extended waiting periods. Organizational factors, including limited surgical capacity, interinstitutional transfers, diagnostic bottlenecks, and administrative processes, contributed to treatment delays and may increase resource utilization and therapeutic complexity. The results support the need to distinguish clinically justified waiting periods from avoidable postponements and highlight the importance of tumor-specific, risk-adapted surgical prioritization. Timely oncological surgery should therefore be considered an integral component of cancer care quality, with potential benefits for survival, disease control, healthcare efficiency, and equity.
Referencias
• Bleicher, R. J., Ruth, K., Sigurdson, E. R., Beck, J. R., Ross, E., Wong, Y.-N., Patel, S. A., Boraas, M., Chang, E. I., Topham, N. S., & Egleston, B. L. (2016). Time to surgery and breast cancer survival in the United States. JAMA Oncology, 2(3), 330–339. https://doi.org/10.1001/jamaoncol.2015.4508
• Flemming, J. A., Nanji, S., Wei, X., Webber, C., Groome, P., & Booth, C. M. (2017). Association between the time to surgery and survival among patients with colon cancer: A population-based study. European Journal of Surgical Oncology, 43(8), 1447–1455. https://doi.org/10.1016/j.ejso.2017.04.014
• Gore, J. L., Lai, J., Setodji, C. M., Litwin, M. S., Saigal, C. S., & Urologic Diseases in America Project. (2009). Mortality increases when radical cystectomy is delayed more than 12 weeks: Results from a Surveillance, Epidemiology, and End Results–Medicare analysis. Cancer, 115(5), 988–996. https://doi.org/10.1002/cncr.24052
• Grass, F., Behm, K. T., Duchalais, E., Crippa, J., Spears, G. M., Harmsen, W. S., Hübner, M., Mathis, K. L., Kelley, S. R., Pemberton, J. H., Dozois, E. J., & Larson, D. W. (2020). Impact of delay to surgery on survival in stage I–III colon cancer. European Journal of Surgical Oncology, 46(3), 455–461. https://doi.org/10.1016/j.ejso.2019.11.513
• Hangaard Hansen, C., Gögenur, M., Tvilling Madsen, M., & Gögenur, I. (2018). The effect of time from diagnosis to surgery on oncological outcomes in patients undergoing surgery for colon cancer: A systematic review. European Journal of Surgical Oncology, 44(10), 1479–1485. https://doi.org/10.1016/j.ejso.2018.06.015
• Hanna, T. P., King, W. D., Thibodeau, S., Jalink, M., Paulin, G. A., Harvey-Jones, E., O’Sullivan, D. E., Booth, C. M., Sullivan, R., & Aggarwal, A. (2020). Mortality due to cancer treatment delay: Systematic review and meta-analysis. BMJ, 371, m4087. https://doi.org/10.1136/bmj.m4087
• Heiden, B. T., Eaton, D. B., Jr., Engelhardt, K. E., Chang, S.-H., Yan, Y., Patel, M. R., Kreisel, D., Nava, R. G., Meyers, B. F., Kozower, B. D., & Puri, V. (2021). Analysis of delayed surgical treatment and oncologic outcomes in clinical stage I non–small cell lung cancer. JAMA Network Open, 4(5), e2111613. https://doi.org/10.1001/jamanetworkopen.2021.11613
• Johnson, B. A., Waddimba, A. C., Ogola, G. O., Fleshman, J. W., Jr., & Preskitt, J. T. (2021). A systematic review and meta-analysis of surgery delays and survival in breast, lung and colon cancers: Implication for surgical triage during the COVID-19 pandemic. The American Journal of Surgery, 222(2), 311–318. https://doi.org/10.1016/j.amjsurg.2020.12.015
• Khorana, A. A., Tullio, K., Elson, P., Pennell, N. A., Grobmyer, S. R., Kalady, M. F., Raymond, D., Abraham, J., Klein, E. A., Walsh, R. M., Monteleone, E. E., Wei, W., Hobbs, B., & Bolwell, B. J. (2019). Time to initial cancer treatment in the United States and association with survival over time: An observational study. PLOS ONE, 14(3), e0213209. https://doi.org/10.1371/journal.pone.0213209
• Kirkegård, J., Mortensen, F. V., Hansen, C. P., Mortensen, M. B., Sall, M., & Fristrup, C. (2019). Waiting time to surgery and pancreatic cancer survival: A nationwide population-based cohort study. European Journal of Surgical Oncology, 45(10), 1901–1905. https://doi.org/10.1016/j.ejso.2019.05.029
• Kovacevic, B., Ewertsen, C., Kristensen, T. S., Penninga, L., & Hansen, C. P. (2025). Progression of resectable pancreatic ductal adenocarcinoma during surgical delay and effects on survival—A propensity score matched study. Pancreatology, 25(2), 228–233. https://doi.org/10.1016/j.pan.2024.11.015
• Mirkin, K. A., Hollenbeak, C. S., & Wong, J. (2018). Time to surgery: A misguided quality metric in early stage pancreatic cancer. Journal of Gastrointestinal Surgery, 22(8), 1365–1375. https://doi.org/10.1007/s11605-018-3730-0
• Müller, P. C., Hodson, J., Kuemmerli, C., Kalisvaart, M., Pande, R., & Roberts, K. J. (2020). Effect of time to surgery in resectable pancreatic cancer: A systematic review and meta-analysis. Langenbeck’s Archives of Surgery, 405(3), 293–302. https://doi.org/10.1007/s00423-020-01893-0
• Murphy, C. T., Galloway, T. J., Handorf, E. A., Wang, L., Mehra, R., Flieder, D. B., & Ridge, J. A. (2015). Increasing time to treatment initiation for head and neck cancer: An analysis of the National Cancer Database. Cancer, 121(8), 1204–1213. https://doi.org/10.1002/cncr.29191
• Murphy, C. T., Galloway, T. J., Handorf, E. A., Egleston, B. L., Wang, L. S., Mehra, R., Flieder, D. B., & Ridge, J. A. (2016). Survival impact of increasing time to treatment initiation for patients with head and neck cancer in the United States. Journal of Clinical Oncology, 34(2), 169–178. https://doi.org/10.1200/JCO.2015.61.5906
• Neal, R. D., Tharmanathan, P., France, B., Din, N. U., Cotton, S., Fallon-Ferguson, J., Hamilton, W., Hendry, A., Hendry, M., Lewis, R., Macleod, U., Mitchell, E. D., Pickett, M., Rai, T., Shaw, K., Stuart, N., Tørring, M. L., Wilkinson, C., Williams, B., … Emery, J. (2015). Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review. British Journal of Cancer, 112(Suppl. 1), S92–S107. https://doi.org/10.1038/bjc.2015.48
• Richards, M. A., Westcombe, A. M., Love, S. B., Littlejohns, P., & Ramirez, A. J. (1999). Influence of delay on survival in patients with breast cancer: A systematic review. The Lancet, 353(9159), 1119–1126. https://doi.org/10.1016/S0140-6736(99)02143-1
• Russell, B., Liedberg, F., Khan, M. S., Nair, R., Thurairaja, R., Malde, S., Kumar, P., Bryan, R. T., & Van Hemelrijck, M. (2020). A systematic review and meta-analysis of delay in radical cystectomy and the effect on survival in bladder cancer patients. European Urology Oncology, 3(2), 239–249. https://doi.org/10.1016/j.euo.2019.09.008
• Samson, P., Patel, A., Garrett, T., Crabtree, T., Kreisel, D., Krupnick, A. S., Patterson, G. A., Broderick, S., Meyers, B. F., & Puri, V. (2015). Effects of delayed surgical resection on short-term and long-term outcomes in clinical stage I non-small cell lung cancer. The Annals of Thoracic Surgery, 99(6), 1906–1913. https://doi.org/10.1016/j.athoracsur.2015.02.022
• Tang, A., Ahmad, U., Raja, S., Bribriesco, A. C., Sudarshan, M., Rappaport, J., Khorana, A., Blackstone, E. H., Murthy, S. C., & Raymond, D. P. (2023). How much delay matters? How time to treatment impacts overall survival in early stage lung cancer. Annals of Surgery, 277(4), e941–e947. https://doi.org/10.1097/SLA.0000000000005307
